日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years

阿柏西普 2 毫克治疗新生血管性年龄相关性黄斑变性：XTEND 3 年随访

期刊:Ophthalmologica
影响因子:1.9
doi:10.1159/000549663
Korobelnik, Jean-François; Chaudhary, Varun; Mitchell, Paul; Kang, Se Woong; Allmeier, Helmut; Lee, JinKyung; Zhang, Xin; Machewitz, Tobias; Bailey, Clare
发表日期：2026
文献求助 收藏

SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration

SPECTRUM：首个全球真实世界研究的早期临床经验，该研究评估了阿柏西普 8 mg 治疗新生血管性年龄相关性黄斑变性患者的疗效。

期刊:
影响因子:
doi:10.1038/s41433-026-04260-3
Bailey, Clare; Lange, Clemens; Chaudhary, Varun; Lanzetta, Paolo; Oubraham, Hassiba; Kirchner, Martin; Machewitz, Tobias; Allmeier, Helmut; Zhang, Xin; Hasanbasic, Zoran; Munk, Marion R
发表日期：2026
文献求助 收藏

Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration

一项全球观察性研究的瑞士队列两年结果，该研究探讨了在新生血管性年龄相关性黄斑变性中使用玻璃体内注射阿柏西普 2 mg 进行主动给药的疗效

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14072370
Hatz, Katja; Ambresin, Aude; Schmid, Martin; Prünte, Christian; Barthelmes, Daniel; Machewitz, Tobias; Allmeier, Helmut; Somfai, Gabor Mark
发表日期：2025
文献求助 收藏

Real-World Intravitreal Aflibercept 2 mg Treatment of Macular Oedema Secondary to Retinal Vein Occlusion in Italy: 24-Month Results from the AURIGA Observational Study

意大利真实世界中使用玻璃体内注射阿柏西普 2 mg 治疗视网膜静脉阻塞继发性黄斑水肿：AURIGA 观察性研究的 24 个月结果

期刊:Ophthalmologica
影响因子:1.9
doi:10.1159/000545534
Grassi, Maria Oliva; Russo, Andrea; Vadalà, Maria; Allmeier, Helmut; Machewitz, Tobias; Varano, Monica
发表日期：2025
文献求助 收藏

2-year results from an observational study of proactive treatment regimens with intravitreal aflibercept 2 mg in patients with nAMD in clinical practice: XTEND study UK cohort

一项观察性研究对临床实践中接受玻璃体内注射阿柏西普 2 mg 治疗的 nAMD 患者进行积极治疗方案的 2 年结果：XTEND 研究英国队列

期刊:
影响因子:
doi:10.1038/s41433-024-03550-y
Bailey, Clare; Chandran, Manju; Gale, Richard; Narendran, Nirodhini; Talks, James; McGoey, Hellen; Keshk, Zinab; Morgan-Warren, Peter; Allmeier, Helmut; Machewitz, Tobias; Patel, Praveen J; Varma, Deepali
AMD
发表日期：2025
文献求助 收藏

Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study

玻璃体内注射阿柏西普治疗视网膜静脉阻塞继发性黄斑水肿的真实世界疗效：AURIGA观察性研究的24个月结果

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-023-00830-w
Giocanti-Aurégan, Audrey; Donati, Simone; Hoerauf, Hans; Allmeier, Helmut; Rittenhouse, Kay D; Machewitz, Tobias; Yang, Chang-Hao
发表日期：2024
文献求助 收藏

Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study

在常规临床实践中，玻璃体内注射阿柏西普治疗糖尿病性黄斑水肿：来自为期 24 个月的 AURIGA 观察性研究的结果

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-023-00829-3
Donati, Simone; Yang, Chang-Hao; Xu, Xun; Mura, Marco; Giocanti-Aurégan, Audrey; Hoerauf, Hans; Allmeier, Helmut; Machewitz, Tobias; Johnson, Kristian T; Santoro, Elina
糖尿病
代谢
发表日期：2024
文献求助 收藏

XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration

XTEND：一项全球观察性研究的两年结果，该研究探讨了在新生血管性年龄相关性黄斑变性中主动给予玻璃体内注射阿柏西普的疗效

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-023-00867-x
Korobelnik, Jean-François; Chaudhary, Varun; Mitchell, Paul; Kang, Se Woong; Tadayoni, Ramin; Allmeier, Helmut; Lee, JinKyung; Zhang, Xin; Machewitz, Tobias; Bailey, Clare
发表日期：2024
文献求助 收藏

Association Between Visual Acuity and Fluid Compartments with Treat-and-Extend Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: An ARIES Post Hoc Analysis

新生血管性年龄相关性黄斑变性患者接受玻璃体内注射阿柏西普治疗后，视力和液体隔室之间的关联：一项 ARIES 事后分析

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-022-00491-1
Chaudhary, Varun; Holz, Frank G; Wolf, Sebastian; Midena, Edoardo; Souied, Eric H; Allmeier, Helmut; Lambrou, George; Machewitz, Tobias; Mitchell, Paul
发表日期：2022
文献求助 收藏

Patients with Neovascular Age-Related Macular Degeneration Requiring Intensive Intravitreal Aflibercept Treatment: An ARIES Post Hoc Analysis

接受强化玻璃体内注射阿柏西普治疗的新生血管性年龄相关性黄斑变性患者：ARIES 事后分析

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-022-00541-8
Wolf, Sebastian; Holz, Frank G; Midena, Edoardo; Souied, Eric H; Lambrou, George; Machewitz, Tobias; Allmeier, Helmut; Mitchell, Paul
发表日期：2022
文献求助 收藏